“To our delight, the Crowdcast predictions often proved to be far more accurate than ‘official’ forecasts”

- New Business Development at a Fortune 100 Pharmaceutical Company

“Love the tool. Lots of fun and engaging”

- Participant in Crowdcast market at top Multimedia and Gaming company via anonymous survey

Customers


Some of the world’s leading companies rely on Crowdcast to help them make more informed and timely decisions

Our customers have achived remarkable results across industries that range from CPG and Retail to Banking and Pharma.

EA Hallmark Monitor360
NERA GM Harvard Business School MIT

EA

Improving product quality, optimizing marketing spend, and aligning a complex high-performance organization.

Hallmark

Bringing new products to market fast and more cost-effectively. Creating efficient communication channels between product and marketing staff and customers and retail partners.

F100 Pharma company

Identifying environmental factors with greatest impact to their business. Implementing programs to proactively respond to these challenges.

Monitor360

Helping the intelligence community make more informed decisions.

NERA

Providing an Industry Information Market, a unique and differentiated service.

World’s largest retailer

Connecting the home office to the front lines. Store managers are collaboratively forecasting efficacy of seasonal marketing campaigns.

F100 financial services and holding company

Improving IT project success. Stakeholders operate according to risk-adjusted project plans that incorporate insights of internal IT staff, vendors, and implementation partners.

GM

Improving time to market by collaboratively identifying technology trends and predicting market success of new products.

Harvard Business School

Harvard Business School is educating students on the power of harnessing collective intelligence and market-based forecasting.

MIT

MIT, in collaboration with the Harvard Business School and Crowdcast, is hosting a prediction market focused on predicting the efficacy of new breast cancer drugs.